Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Fund Type: Closed-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Tekla Healthcare Investors

+ Add to Watchlist

XHQHX:US

32.82 USD 0.25 0.77%

As of 20:00:00 ET on 01/29/2015.

Snapshot for Tekla Healthcare Investors (XHQHX)

Year To Date: +4.09% 3-Month: +8.78% 3-Year: +35.19% 52-Week Range: 24.77 - 33.37
1-Month: +2.72% 1-Year: +31.38% 5-Year: +26.30% Beta vs BTK: 0.81

Mutual Fund Chart for XHQHX

No chart data available.
  • XHQHX:US 32.82
  • 1M
  • 1Y
Interactive XHQHX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for XHQHX

Tekla Healthcare Investors Fund is a diversified, closed-end management investment company incorporated in the USA. The Trust's objective seeks long term capital appreciation. The Trust will invest 80% of its assets in health services and medical technology companies, that have significant potential for above-average growth.

Inception Date: 04-22-1987 Telephone: 1-617-772-8500
Managers: DANIEL R OMSTEAD
Web Site: www.teklacap.com

Fundamentals for XHQHX

NAV (on 2015-01-29) 32.82
Assets (M) (on 2015-01-29) 1,185.83
Fund Leveraged N
Minimum Investment 0.00
Minimum Subsequent Investment 0.00

Dividends for XHQHX

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net (on 2014-11-24) 0.59
Dividend Yield (ttm) 6.70

Fees & Expenses for XHQHX

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 0.95
Redemption Fee 0.00
12b1 Fee 0.00
Expense Ratio 1.13

Top Fund Holdings for XHQHX

Filing Date: 12/31/2013
Name Position Value % of Total
Gilead Sciences Inc 1,039,942 78,151,641 10.619%
Celgene Corp 706,182 59,658,255 8.106%
Regeneron Pharmaceuticals Inc 178,740 49,196,398 6.685%
Biogen Idec Inc 132,195 36,981,551 5.025%
Alexion Pharmaceuticals Inc 259,405 34,516,429 4.690%
Amgen Inc 286,769 32,737,549 4.448%
Actavis plc 158,892 26,693,856 3.627%
Vertex Pharmaceuticals Inc 346,735 25,762,411 3.501%
Perrigo Co PLC 154,896 23,770,340 3.230%
iShares Nasdaq Biotechnology E 97,826 22,212,372 3.018%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil